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Objective: To evaluate whether mandatory fortification of grain products with folic acid in the US 
is associated with changes in histone methylation in cells involved in cervical carcinogenesis.
Methods: Cervical specimens obtained before (1990 to 1992) and after mandatory folic acid 
fortification (2000 to 2002) were used to examine the degree of histone methylation (H3 Lys-9) 
by immunohistochemistry. 91 women (51 before and 40 after fortification) were diagnosed with 
cervical intraepithelial neoplasia (CIN) grade 3 or carcinoma in situ (CIS) and sections utilized 
in the study also contained normal, reactive or metaplastic cervical epithelium, CIN 1 or CIN 2. 
64 women (34 before and 30 after fortification) were free of CIN and these sections contained 
only normal or reactive cervical epithelium. Immunohistochemical staining for H3 Lys-9, its 
assessment in different cell or lesion types and data entry were blinded for fortification status. 
For each cell type or lesion category we used PROC MIXED in SAS with the specimen identifier 
as a random effect and the robust variance estimator to estimate age- and race-adjusted intensity 
score for H3 Lys-9 in the pre- and post-fortification periods.
Results: Degree of H3 Lys-9 methylation was significantly higher (P  0.0001) in CIN 2 
lesions (CIN 2, CIN 3 and CIS) than in CIN 1 lesions (CIN 1, normal, reactive and metaplastic), 
in both pre- and post-fortification CIN 3/CIS specimens. Age- and race-adjusted mean H3 Lys-9 
score was significantly higher in all cell or lesion types in CIN 3/CIS specimens obtained in 
the post-fortification period compared to pre-fortification period (P  0.05, all comparisons). 
In contrast, in specimens obtained from women free of CIN, Lys-9 methylation in normal/
reactive cervical epithelium was significantly lower in post-fortification specimens than in 
pre-fortification specimens (P = 0.03).
Conclusions: Higher levels of Lys-9 methylation in CIN 2 compared to CIN 1 lesions suggest 
that higher Lys-9 methylation is associated with progression of lower grade CIN to higher grade 
CIN. Higher Lys-9 methylation in cervical tissues of women diagnosed with CIN 3 in the post-
fortification period than in pre-fortification period suggest that fortification may adversely affect 
histone methylation in already initiated cells. Lower Lys-9 methylation in normal/reactive cervical 
cells of women free of CIN in the post-fortification period than pre-fortification on the other hand 
suggests that fortification is likely to protect against initiation of carcinogenic process in the cervix. 
These results suggest that mandatory fortification with folic acid in the US seems to have different 
effects on cancer depending on the stage of carcinogenesis. Because this is the first study to report 
folic acid fortification-associated differences in histone methylation and because of the limitations 
inherent to the approach we have taken to demonstrate these differences, validation of the results in 
other study populations or with other techniques for assessing histone methylation is necessary.
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Background
The addition of folic acid (synthetic form of folate, 
a water-soluble B vitamin) to grain products which was 
mandated by the Food and Drug Administration (FDA) in 
1998 was directed towards the prevention of neural tube 
defects (NTDs). The potential effects of increasing folate 
intake population-wide on other human health conditions 
are largely unclear at this point, but concerns have been 
raised about possible adverse effects of higher folate 
status on cognitive impairment and anemia,1 immune 
function,2 reducing the efficacy of anti-epileptic drugs or 
anti-folate chemotherapy or promoting the progression of 
initiated cancer cells. Since folic acid fortification began 
in the USA, supra-physiologic serum folate concentrations 
(45 nmol/L or 19.8 ng/mL) have been documented in 
about 25% of the US population.3 These supra-physiologic 
folate concentrations are likely to be associated with the 
presence of unmetabolized folic acid.4 Evidence suggests that 
unmetabolized folic acid found in blood after the ingestion of 
supplements or fortified foods may have adverse effects on 
folate binding proteins or transporters5 possibly interfering 
with normal folate metabolism. Although it is possible 
that unmetabolized folic acid may have different effects on 
already initiated cancer cells compared to uninitiated cells, 
this has not been shown directly for any cancer type. However, 
it is also important to understand that fortification will not 
only raise the concentrations of unmetabolized folic acid 
but also the concentrations of total folate in the body which 
could have disease protective effects.
Because the changes in total folate status and/or the 
presence of un-metabolized folic acid as a result of folic 
acid fortification are likely to alter folate-related molecular 
mechanisms which are hallmarks of cancer, such as the 
methylation of DNA and histones, or the expression of folate 
pathway enzymes such as DNA methyl transferases (Dnmts), 
we have investigated changes in such events in relation to the 
folic acid fortification program in the USA. We have previ-
ously reported that global DNA methylation (assessed by an 
immunohistochemical method) was not significantly different 
in cervical tissues of women diagnosed with cervical intraepi-
thelial neoplasia (CIN 3), in the pre-folic acid fortification 
period compared to post-folic acid fortification period.6
Our recent results also suggested that degree of 
expression of DNA methyltransferase 1 (Dnmt 1) was 
significantly higher in all lesion types detected in women 
diagnosed with CIN 3 in the post-fortification period 
compared to pre-fortification period.7 Because the degree 
of Dnmt 1 expression was significantly higher in CIN 2 
lesions compared to CIN 1 lesions, we believe that higher 
expression of Dnmt 1 may be a risk factor for the develop-
ment of cervical cancer (CC). Therefore, folate fortification 
is likely to exert adverse effects in women diagnosed with 
pre-cancer lesions possibly via alterations in Dnmt 1.
Importantly, however, expression of Dnmt 1 assessed by 
the same method in cervical epithelium of women free of CIN 
in the two fortification periods (n = 34, pre and n = 30, post) 
demonstrated that the degree of Dnmt 1 expression was not 
significantly different between the two fortification periods 
(unpublished data). Although these women are free of CIN, 
they are at high risk for developing CC because they were 
refereed for evaluation by colposcopically directed biopsies 
as a result of abnormal pap diagnoses and therefore likely to 
be exposed to carcinogenic types of human papillomaviruses 
(HPVs), the main risk factor for CC. These observations and 
results suggested that higher folate intake due to folic acid 
fortification and its possible effects on the expression of 
Dnmt 1 expression are likely to increase the risk of malignant 
transformation of initiated cells as in CIN 3 to CC, but these 
fortification associated changes may not pose a risk for those 
in women who are at risk for CC, but not diagnosed with 
cervical pre-cancer (uninitiated cells). This is an interesting 
and possible differential effect of higher folic acid on initiated 
cells compared to uninitiated cells. The purpose of the current 
study was to investigate whether folic acid fortification has 
similar differential effects on histone methylation, another 
hallmark event for cancer.
Materials and methods
study design
The study population consisted of women at risk for 
developing CC based on abnormal pap diagnoses reported 
by Health Departments in Alabama who were referred to a 
colposcopy clinic at the University of  Alabama at Birmingham 
(UAB) for further examination by colposcopically directed 
cervical biopsies. Paraffin-embedded biopsy specimens, 
archived in the Department of Pathology at the University 
of Alabama at Birmingham (UAB) from these women were 
used to evaluate the degree of H3 Lys-9 histone methylation 
in women diagnosed with CIN 3 lesions where precancerous 
cells are in the entire epithelial layer of the cervix or in women 
free of CIN before (1990 to 1992) and after the initiation of 
the national program of fortification of grains with folic acid 
(2000 to 2002). We used randomly selected specimens from 
51 and 40 women diagnosed with CIN 3 (based on available 
pathology report) from the pre- and post-fortification periods, 
respectively, and specimens from 34 and 30 women free of International Journal of Women’s Health 2009:1 133
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CIN (based on available pathology report) from the pre- and 
post-fortification periods respectively. Tissue sections stained 
with H and E were requested for all these specimens and the 
study pathologist (WCB) reviewed them to identify CIN 3 
lesions or other lesions in the same specimen (normal, reac-
tive or metaplastic cervical epithelium, CIN 1 [only the 
lower one-third of cells in the epithelial layer of the cervix 
are abnormal], CIN 2 [up to two-thirds of the epithelial layer 
contains precancerous cells] or CIS [precancerous cells are 
in the entire epithelial layer of the cervix]). Sections from 
women free of CIN were also examined by WCB to assure 
that they were free of CIN lesions. We reviewed medical 
charts in an attempt to obtain additional data on, for example, 
smoking and use of vitamin supplements, but this informa-
tion was unavailable for most women and therefore was not 
used in this study. Data on race and age were available for all 
women. All specimens were given a code and the individu-
als who were involved with immunohistochemical staining, 
evaluation of H3 Lys-9 histone methylation and data entry 
were blinded for the fortification status.
Histological criteria and classification 
of lesions
Seven histological cell or lesion types, namely, normal, 
reactive, metaplastic cervical epithelial cells, CIN 1, CIN 2, 
CIN 3 or CIS were identified by the study pathologist in 
specimens specified as CIN 3 by the pathology report 
(51 women in the pre-fortification period and 40 women in 
the post-fortification period). All these cell or lesion types 
found in each section were evaluated separately for H3 Lys-9 
histone methylation. The total number of lesions identified in 
pre-fortification specimens was 112 (34 normal, 18 reactive, 
2 metaplastic, 5 CIN 1, 6 CIN 2, 38 CIN 3 and 9 CIS). 
The total number of lesions identified in post-fortification 
specimens was 98 (34 normal, 23 reactive, 2 metaplastic, 
1 CIN 2, 28 CIN 3 and 10 CIS). All specimens specified as 
free of CIN by the pathology report (34 in the pre-fortification 
period and 30 in the post-fortification period) contained 
normal or reactive cervical epithelium only.
Immunohistochemical analysis
Our methods of immunohistochemical analysis with various 
antibodies (with/without various antigen retrieval techniques) 
have been reported previously.8,9 A comparison of results with 
and without different antigen retrieval techniques revealed 
that the protocol described below gave the best results for 
the polyclonal antibody specific for anti-dimethyl- histone 3 
(Lys9, Upstate 07-212). Briefly, the slides containing 4 µm 
thick paraffin tissue sections were deparaffinized in xylene, 
placed in 0.01 M citric acid, pH 6.0, and boiled in a pressure 
cooker set at full power for 10 minutes. After antigen 
retrieval, the sections were cooled and rinsed in deionized 
H2O (dH2O). The sections were then rinsed with Tris-buffered 
saline and treated with 3.0% H2O2 for 5 minutes to quench 
endogenous peroxidase activity. Sections were incubated 
with preimmune goat serum (3%) for 20 minutes at room 
temperature to suppress nonspecific staining and then subse-
quently incubated with Lys9 antibody (1:50 concentration) 
for 1 hour at room temperature. After washing thoroughly 
with Tris-buffered saline, the primary antibody was detected 
using a multi-species system (Signet Laboratories, Inc., 
Dedham, MA, USA). The antibody-antigen complex was 
visualized using a 3, 3-diaminobenzidine substrate kit 
according to the manufacturer’s instructions (Biogenex, 
Inc., San Ramon, CA, USA); and lightly counterstained 
with haematoxylin. Slides were sequentially dipped in 70%, 
95% and 100% ethanol (3 minutes each); and then were 
allowed to dry slightly. Finally, slides were dipped in xylene 
3 times (3 minutes each) after which they were protected 
with cover slips.
Assessment of immunostaining
Immunostaining for H3 Lys-9 was localized mainly in the 
nuclei of cells. Nuclear staining in cells with or without 
cytoplasmic staining was interpreted as a positive reaction. 
The degree of H3 Lys-9 methylation in the nuclei was 
recorded independently by two observers (WCB and JEC) as 
a percentage of cells positive for H3 Lys-9 based on a visual 
assessment of the intensity of brown reaction product within 
the cell nucleus on a scale of 0 (no staining) to 4+ (intense 
staining). All evaluations were done separately in the basal, 
bottom-half and top-half layer of the normal, reactive and 
metaplastic cervical epithelium and CIN 1, 2 and 3. This 
approach is time consuming, but allows obtaining a more 
accurate estimate on the percentage of cells positive for 
H3 Lys-9 in each cell or lesion type. Because the basal, 
bottom-half and top-half layers cannot be separated in CIS, 
one reading was given for those lesions. The degree of H3 
Lys-9 methylation was reported as an intensity score which 
was derived by multiplying the percentage of cells positive 
for H3 Lys-9 at each intensity score by the appropriate 
intensity score. For all cell or lesion types the intensity score 
in the basal, bottom-half and top-half layer were averaged to 
obtain the average degree of H3 Lys-9 methylation in each 
cell or lesion type. The readings from the two observers were 
averaged for each cell or lesion type and thus the degree of International Journal of Women’s Health 2009:1 134
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H3 Lys-9 methylation reported is the average of the two 
observers.
statistical analysis
In the analyses, the dependent variable was the staining 
intensity score of H3 Lys-9. The independent variables of 
interest were 1) the period of diagnosis (before or after 
implementation of the folate fortification program) and 2) in 
CIN 3 specimens, the diagnostic category of the tissue exam-
ined combined into CIN I which included normal, reactive 
or metaplastic cervical epithelium and CIN 1 or CIN 2 
which included CIN 2, CIN 3 and CIS. This grouping is 
based on the clinical significance of the pathological findings: 
the CIN I group included tissue with findings that are not 
considered to be true pre-neoplastic, whereas the CIN 2 
category included CIN 2, CIN 3/CIS, which are considered 
to be true pre-neoplastic lesions of the cervix. Because a 
patient’s specimen could contain areas with pathologic find-
ings compatible with more than one category, the degree of 
H3 Lys-9 methylation was evaluated independently in each 
area and the same woman may have contributed information 
on the degree of H3 Lys-9 methylation in more than one 
diagnostic category. We used mixed linear models and robust 
variance estimators to properly take into account the potential 
correlation of multiple findings from the same subject. The 
independent variables of interest in women free of CIN were 
1) the period of diagnosis (before or after implementation 
of the folic acid fortification program) 2) normal or reactive 
cervical epithelium combined, as there was no difference in 
staining intensities between these two categories.
For each cell type or lesion category we used PROC 
MIXED in SAS with the specimen identifier as a random 
effect and the robust variance estimator to estimate age- and 
race-adjusted intensity score for H3 Lys-9 in the pre- and 
post-fortification periods. The differences in intensity scores 
in the pre-fortification compared to the post-fortification 
group were considered significant at P  0.05. To determine 
whether the pattern of H3 Lys-9 methylation has changed 
with fortification in women diagnosed with CIN 3, we 
assessed whether the intensity score for H3 Lys-9 in CIN 1 
and CIN 2 specimens in the pre-fortification period was 
similar to that in the post-fortification period. In an additional 
analysis we considered the within-woman variation in the 
degree of H3 Lys-9 methylation across diagnostic categories. 
To accomplish this, we summed the H3 Lys-9 positive cells 
in all CIN 1 lesions and subtracted the total from the sum 
for H3 Lys-9 positive cells in CIN 2 lesions, to obtain a 
within-woman H3 Lys-9 difference. Next, we compared the 
distribution of within-woman H3 Lys-9 differences in the 
pre- and post-fortification period. The mean difference in 
the pre-fortification period was compared to that from the 
post-fortification using a t-test.
Results
As shown in Table 1, in the pre-fortification period, 67% 
of the women diagnosed with CIN 3 were Caucasian 
Americans (CAs) and the rest were African-Americans 
(AAs) while in the post-fortification group 63% were CAs 
and the rest AAs. The mean age of the pre-fortification group 
(33.73 ± 13.12) was similar to that of the post-fortification 
group (31.55 ± 8.71). Among women free of CIN, in the 
pre-fortification period, 44% were Caucasian Americans 
(CAs) and the rest were African-Americans (AAs) while 
in the post-fortification group 70% were CAs and the 
rest AAs and the mean age of the pre-fortification group 
(25.15 ± 4.91) was younger than the post-fortification group 
(41.90 ± 10.65).
Age- and race-adjusted H3 Lys-9 score was significantly 
higher in all lesion types detected in CIN 3 specimens from 
the post-fortification period compared to the pre-fortification 
period (P  0.05, all comparisons). Similarly, when lesions 
were combined into two main groups (CIN 1 lesions 
and CIN 2 lesions), the H3 Lys-9 score were significantly 
higher in both CIN 1 lesions and CIN 2 lesions in the 
post-fortification period compared to the pre-fortification 
period (P  0.005 for all comparisons). The degree of 
H3 Lys-9 methylation was significantly higher in CIN 2 
lesions compared to CIN 1 lesions in both pre- and post-
fortification CIN3 specimens. The age- and race-adjusted 
H3 Lys-9 score was significantly lower in normal or reactive 
cervical epithelium in specimens free of CIN in the post-
fortification period compared to the pre-fortification period 
(P = 0.0262).
Figure 1 demonstrates the H3 Lys-9 methylation status of 
CIN 3 and normal cervical epithelium detected in the same 
section; higher degree of H3 Lys-9 methylation in a CIN 3 
lesion (B) compared to normal cervical epithelium (A) in pre-
fortification period, higher degree of H3 Lys-9 methylation 
in a CIN 3 lesion (D) compared to normal cervical epithe-
lium (C) in post-fortification period and higher degree of 
H3 Lys-9 methylation in normal cervical epithelium in the 
post-fortification period (C) compared to pre-fortification 
period (A) and higher degree of H3 Lys-9 methylation in 
CIN 3 in the post-fortification period (D) compared to pre-
fortification period (B). Figure 2 demonstrates the lower 
H3 Lys-9 methylation in normal cervical epithelium in the International Journal of Women’s Health 2009:1 135
Histone methylation and folic acid fortification Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
post-fortification period (B) compared to pre-fortification 
period (A) in specimens free of CIN.
Discussion
Histones are a group of evolutionarily conserved proteins 
that package and organize DNA in cells. Chemical modi-
fication of histones such as methylation results in aberrant 
gene regulation, DNA damage, cell cycle defects, genomic 
instability, all of which are hallmarks of cancer.10 Recently, 
altered histone methylation has also emerged as key to 
DNA methylation-related gene silencing and this type of 
gene silencing in cancer is accompanied by an increase in 
H3 Lys9 methylation.11 We observed that the degree of H3 
Lys-9 methylation is higher in higher grade lesions (CIN 2) 
compared to lower grade lesions (CIN 1). This suggests 
that increases in H3 Lys9 methylation are likely to facilitate 
malignant transformation of cervical cells at risk to pre-
cancerous cells or cancerous cells. Our results suggest that 
the degree of H3 Lys9 methylation is higher in women diag-
nosed with CIN 3 in the post-folic acid fortification period 
compared to pre-folic acid fortification period. Because CIN 
3 is a precursor lesion for the development of invasive CC 
and because the transformation of CIN 3 to invasive CC is 
likely to be accelerated by higher histone methylation, these 
observations raise concerns about the possibility that manda-
tory folic acid fortification program in US may have hastened 
progression to cancer in women diagnosed with pre-cancer. 
On the other hand, higher folate status in the post folic acid era 
is associated with lower histone methylation in women at risk 
for developing cervical pre-cancer, but free of precancerous 
changes and this is likely to prevent transformation of HPV 
exposed cervical epithelium to pre-cancer or cancer.
Mechanisms by which folate may alter histone methyla-
tion are not clearly understood. However, a typical western 
diet characterized by lower intakes of folate-rich natural 
foods has been shown to lower the ratio of S-adenosyl-
methionine (SAM) versus S-adenosyl-homocysteine (SAH), 
and a low SAM/SAH ratio is known to inhibit the activity 
of several methyltransferases.12 SAM/SAH ratio is likely to 
be higher in the post fortification era due to higher methyl 
availability and conversion of SAH to SAM and this may 
result in higher expression of histone methyltransferases and 
thus higher histone methylation in initiated cells. Because 
we observe significantly opposite effects of higher folate on 
histone methylation in uninitiated cells, altered SAH/SAM is 
likely to have different effects on methyltransferases based 
on the stage of the carcinogenic process.
The differential effects of folic acid fortification on 
histone methylation in initiated versus uninitiated cells may 
also be explained by the influence of Dnmt 1 on histone 
methylation. Treatment with the DNA methyltransferase 
inhibitor 5-aza-2´-deoxycytidine (5Aza-dC) is shown to 
reduce Lys-9 methylation at silenced loci and results in 
reactivation of tumor suppressor genes13 suggesting that the 
observed higher Dnmt expression in CIN 3 lesions may have 
contributed to higher histone methylation in CIN 3 lesions. 
Expression of Dnmt 1 was not higher in the post-folic acid 
period in uninitiated cells and this may explain the lower 
histone methylation in normal/reactive cervical epithelium 
in the post-folic acid period. Although further research is 
Table 1 Degree of expression of H3 Lys-9 in cervical cells in the pre- and post-fortification periods
Specimens of CIN 3 Pre-fortification (1990–1992) Post-fortification (2000–2002) P valuesb
AA CA AA + CA AA CA AA + CA
number of subjects 17 34 51 15 25 40
Age, years (mean ± sD) 33.00 ± 13.35 34.09 ± 13.19 33.73 ± 13.12 30.07 ± 7.29 32.44 ± 9.49 31.55 ± 8.71
Intensity score for H3 Lys-9a
cIn 1 0.46 ± 0.10 0.57 ± 0.07 0.51 ± 0.06 0.73 ± 0.10 0.85 ± 0.06 0.79 ± 0.06 0.0024
cIn 2 0.71 ± 0.10 0.80 ± 0.10 0.76 ± 0.07 1.15 ± 0.12 1.17 ± 0.07 1.16 ± 0.07 0.0002
Specimens free of CIN
number of subjects 19 15 34 9 21 30
Age, years (Mean ± sD) 25.21 ± 5.75 25.07 ± 3.77 25.15 ± 4.91 46.00 ± 14.71 40.14 ± 8.19 41.90 ± 10.65
Intensity score for H3 Lys-9a
normal or reactive 
cervical epithelium
0.71 ± 0.07 0.70 ± 0.10 0.71 ± 0.06 0.54 ± 0.06 0.52 ± 0.05 0.53 ± 0.04 0.0262
aValues are means ± se, adjusted for age and race; bP comparing AA + CA for pre- and post-fortification.
Abbreviations:   AA,   African   Americans; cA, caucasian   Americans; cIn, cervical intraepithelial neoplasia.International Journal of Women’s Health 2009:1 136
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necessary to clarify this relation, the explanation is biologi-
cally plausible because previous research has established a 
direct connection between the enzymes responsible for DNA 
methylation and histone methylation.14
These preliminary findings should be interpreted in 
light of the limitations inherent to a study of this nature. For 
example, pre- and post-fortification specimens were collected 
several years apart and therefore, we cannot completely 
exclude the possibility that observed differences in degree 
of H3 Lys-9 methylation are an effect of storage time on 
antibody binding, or due to time-dependent changes in the 
quality of the DNA. However, because we demonstrate either 
no change or lower degree of expression in Dnmt 1 or H3 
Lys-9, respectively in post-fortification compared to pre-
fortification suggest that time-dependent changes in DNA 
are unlikely to explain the observed differences in degree 
A B
C D
B A
Figure 1 Expression of H3 Lys-9 methylation in pre-fortification normal cervical epithelium (A); pre-fortification CIN 3 lesion (B); post-fortification normal cervical epithelium 
(C) and post-fortification CIN 3 lesion (D).
A B
Figure 2 Expression of H3 Lys-9 methylation in pre-fortification normal cervical epithelium (A) and post-fortification normal cervical epithelium (B) in a specimen free of cIn.International Journal of Women’s Health 2009:1
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of H3 Lys-9 methylation. Because of the cross-sectional 
design, this study cannot demonstrate a causal link between 
altered H3 Lys-9 methylation and cancer risk. We attempted 
to associate degree of H3 Lys-9 methylation with disease 
risk by evaluating recurrence of pre-cancer, progression to 
invasive cancer or survival of these patients, but were unable 
to retrieve this information from patient records. For other 
cancers (example, colorectal), histone methylation is shown 
to be a critical modification responsible for maintenance of 
DNA methylation-related gene silencing, an important risk 
profile for cancer development and prognosis. Therefore, 
the observed association between folic acid fortification 
and changes in histone methylation in cervical tissues are 
important preliminary findings.
Another limitation of our study is that at the individual 
subject level, we have no environmental or lifestyle data and 
data to support that folic acid intake, blood levels or cellular 
levels of folate have increased as a result of fortification. In 
a population-based study, however, it is fair to assume that 
everyone had the opportunity to be exposed to fortified food 
items after fortification had begun and population-based 
studies have shown that serum folate concentrations have sig-
nificantly increased after folic acid fortification.15 Although 
the limitations cited call for caution in interpreting the results 
generated by this study, the finding that the response of initi-
ated cells to higher folic acid may be different from that of 
normal or uninitiated cells16 is biologically plausible and 
warrants further investigation.
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